Could your own stem cells ease Parkinson's? new trial results are in
NCT ID NCT04928287
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This phase 2 study tested whether a person's own stem cells (called HB-adMSCs) could help control Parkinson's disease symptoms. Twenty-four adults with early to moderate Parkinson's received either stem cell infusions or a placebo over 32 weeks, and were followed for safety. The main goal was to see if the treatment improved daily living skills and movement, as measured by standard Parkinson's rating scales. While the study is complete, it focused on safety and symptom control rather than a cure.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PARKINSON DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Hope Biosciences Stem Cell Research Foundation
Sugar Land, Texas, 77478, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Planning ahead: could a simple program transform Parkinson's care?
- Sound waves vs. Parkinson's: can ultrasound calm tremors and stiffness?
- Can a nudge in your chart unlock Life-Saving genetic clues?
- Can MRI reveal the Brain's response to deep brain stimulation?
- Can we outsmart Gaucher's hidden toll on lungs, bones, and brain?
- Could a brain disease change behavior years before diagnosis?